Pre-emptive treatment of recurrent hepatitis C infection

被引：7

作者：

Charlton, M ^{[1
]}

机构：

[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA

来源：

LIVER TRANSPLANTATION | 2002年 / 8卷 / 10期

关键词：

D O I：

10.1053/jlts.2002.35859

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Data discussed in summary suggest that post-LT HCV infection may be most amenable to therapy initiated on a prophylactic basis early in the post-LT course. However, a definitive comparison of the safety and efficacy of antiviral therapy initiated prophylactically versus on histological recurrence has not been performed, nor has any large study of antiviral therapy of post-LT HCV infection.

引用

页码：S50 / S54

页数：5

共 53 条

[31]

Manzarbeitia C, 2001, HEPATOLOGY, V34, p406A

[32] Prophylaxis against HCV recurrence after liver transplantation: Effect of interferon and ribavirin combination [J].

Mazzaferro, V ;

Regalia, E ;

Pulvirenti, A ;

Tagger, A ;

Andreola, S ;

Pasquali, M ;

Baratti, D ;

Romano, F ;

Palazzo, U ;

Zuin, M ;

Bonino, F ;

Ribero, ML ;

Gennari, L .

TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :519-521

[33] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C [J].

McHutchison, JG ;

Gordon, SC ;

Schiff, ER ;

Shiffman, ML ;

Lee, WM ;

Rustgi, VK ;

Goodman, ZD ;

Ling, MH ;

Cort, S ;

Albrecht, JK .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1485-1492

[34] Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy [J].

Menon, KVN ;

Poterucha, JJ ;

El-Amin, OM ;

Burgart, LJ ;

Kremers, WK ;

Rosen, CB ;

Wiesner, RH ;

Charlton, M .

LIVER TRANSPLANTATION, 2002, 8 (07) :623-629

[35] Successful rescue of severe recurrent hepatitis C with interferon and ribavirin in a liver transplant patient [J].

Muramatsu, S ;

Ku, YS ;

Fukumoto, T ;

Iwasaki, T ;

Tominaga, M ;

Kusunoki, N ;

Yoon, S ;

Kuroda, Y .

TRANSPLANTATION, 2000, 69 (09) :1956-1958

[36] Demographic determinants of hepatitis C virus seroprevalence among blood donors [J].

Murphy, EL ;

Bryzman, S ;

Williams, AE ;

CoChien, H ;

Schreiber, GB ;

Ownby, HE ;

Gilcher, RO ;

Kleinman, SH ;

Matijas, L ;

Thomson, RA ;

Nemo, GJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (13) :995-1000

[37] Causes of graft loss following liver transplantation for chronic hepatitis C [J].

OReilly, PM ;

Rosen, HR ;

Shackleton, CR ;

McDiarmid, S ;

Holt, C ;

Busuttil, RW ;

Martin, P .

TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :526-528

[38] Liver transplantation in hepatitis C. A Spanish multi-centre experience [J].

Prieto, M ;

Berenguer, M ;

Rimola, A ;

Loinaz, C ;

Barrios, C ;

Clemente, G ;

Figueras, J ;

Vargas, V ;

Casafont, F ;

Pons, JA ;

Herrero, JI .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (09) :771-776

[39] High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation:: Relationship with rejection episodes [J].

Prieto, M ;

Berenguer, M ;

Rayón, JM ;

Córdoba, J ;

Argüello, L ;

Carrasco, D ;

García-Herola, A ;

Olaso, V ;

De Juan, M ;

Gobernado, M ;

Mir, J ;

Berenguer, J .

HEPATOLOGY, 1999, 29 (01) :250-256

[40] Graft loss following liver transplantation in patients with chronic hepatitis C [J].